These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12744205)

  • 1. Cytogenetic techniques for myeloid disorders.
    Swansbury J
    Methods Mol Biol; 2003; 220():43-57. PubMed ID: 12744205
    [No Abstract]   [Full Text] [Related]  

  • 2. The myeloid disorders: background.
    Swansbury J
    Methods Mol Biol; 2003; 220():23-42. PubMed ID: 12744204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome preparations from bone marrow in acute lymphoblastic leukemia: cytogenetic techniques.
    Watmore A
    Methods Mol Biol; 2003; 220():83-91. PubMed ID: 12744208
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ph1 chromosome in chronic myeloid leukemia. Its diagnostic and prognostic value].
    de Vinuesa ML; de Salum SB
    Medicina (B Aires); 1981; 41(3):293-6. PubMed ID: 6948147
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of cytogenetic methods in the diagnosis and differential diagnosis of myeloproliferative diseases (review of the literature and personal data)].
    Fleĭshman EV; Volkova MA
    Probl Gematol Pereliv Krovi; 1970 Aug; 15(8):53-8. PubMed ID: 4935743
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytogenetic studies in chronic myeloproliferative disorders.
    Carbonell F; Ganser A; Heimpel H
    Acta Haematol; 1983; 69(3):145-51. PubMed ID: 6404096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnostic significance of the Ph chromosome].
    Hampel KE
    Verh Dtsch Ges Inn Med; 1967; 73():457-60. PubMed ID: 5242223
    [No Abstract]   [Full Text] [Related]  

  • 9. [Variability of cytogenetic results obtained with the direct method and short-term cultures in 32 patients with various hematological disorders].
    Benitez J; Sánchez Fayos J; Bello MJ; Valcarcel E
    Sangre (Barc); 1983; 28(4):393-400. PubMed ID: 6581541
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytogenetic studies of spleen cells in some myeloproliferative syndromes].
    Maj S; Pawelski S
    Acta Haematol Pol; 1971; 2(1):47-53. PubMed ID: 5293227
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
    Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-analytical parameters associated with unsuccessful karyotyping in myeloid neoplasm: a study of 421 samples.
    Santos MFM; Oliveira FCAC; Kishimoto RK; Borri D; Santos FPS; Campregher PV; Silveira PAA; Hamerschlak N; Mangueira CLP; Duarte FB; Crepaldi AH; Salvino MA; Velloso EDRP
    Braz J Med Biol Res; 2019 Feb; 52(2):e8194. PubMed ID: 30785480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.
    Beyer V; Mühlematter D; Parlier V; Cabrol C; Bougeon-Mamin S; Solenthaler M; Tobler A; Pugin P; Gregor M; Hitz F; Hess U; Chapuis B; Laurencet F; Schanz U; Schmidt PM; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2005 Jul; 160(2):97-119. PubMed ID: 15993266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of myeloproliferative disorder presenting as chronic neutrophilic leukemia with detection of Ph1 chromosome in long-term culture].
    Sanada I; Yamamoto S; Ogata M; Kawakita M; Kawano F; Takatsuki K; Fujiwara H; Tanaka R; Kumagai E
    Rinsho Ketsueki; 1985 Mar; 26(3):429-35. PubMed ID: 3861890
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytogenetic studies in chronic granulocytic leukaemia.
    Dougan L; Onesti P; Woodliff HJ
    Australas Ann Med; 1967 Feb; 16(1):52-61. PubMed ID: 5230982
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization.
    Mrózek K; Tanner SM; Heinonen K; Bloomfield CD
    Genes Chromosomes Cancer; 2003 Nov; 38(3):249-52. PubMed ID: 14506699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic and clinical study of myeloid leukemia].
    Jiang SH; Shi WY; Liu H; Song GQ; Sun GX; Lu W; Liu DF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):571-3. PubMed ID: 17922430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic studies in myeloproliferative disorders.
    Borgaonkar DS
    Cytologia (Tokyo); 1972 Jun; 37(2):271-80. PubMed ID: 4509823
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: The role of cytogenetics in hematology.
    Rowley JD
    Blood; 1976 Jul; 48(1):1-7. PubMed ID: 1065388
    [No Abstract]   [Full Text] [Related]  

  • 20. Myeloid neoplasms with der(1)t(1;19) may constitute a specific entity characterized by a cytogenetic biomarker and gene mutations involved in DNA methylation.
    Salgado RN; Menezes J; Calvente M; Suela J; Acquadro F; Martínez-Laperche C; Flores R; Trujillo M; Alvarez S; Cigudosa JC
    Leuk Lymphoma; 2014 Nov; 55(11):2652-5. PubMed ID: 24635575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.